{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:29:03Z","timestamp":1790418543124,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"National Institute of Health","doi-asserted-by":"publisher","award":["R01DK097379"],"award-info":[{"award-number":["R01DK097379"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.coph.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T06:49:20Z","timestamp":1504075760000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Intestinal patch systems for oral drug delivery"],"prefix":"10.1016","volume":"36","author":[{"given":"Amrita","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mitragotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2017.08.005_bib0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13300-013-0034-y","article-title":"Adherence to therapies in patients with type 2 diabetes","volume":"4","author":"Garcia-Perez","year":"2013","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.coph.2017.08.005_bib0250","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.coph.2017.08.005_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.coph.2017.08.005_bib0260","series-title":"Adherence to Long-Term Therapies","author":"World Health Organization","year":"2003"},{"key":"10.1016\/j.coph.2017.08.005_bib0265","series-title":"Comparison of Pharmacokinetics and Efficacy of Oral and Injectable Medicine","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.coph.2017.08.005_bib0270","series-title":"Global Oral Drug Delivery Market Research Report","year":"2017"},{"key":"10.1016\/j.coph.2017.08.005_bib0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","article-title":"Oral lipid-based drug delivery systems\u2014an overview","volume":"3","author":"Kalepu","year":"2013","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.coph.2017.08.005_bib0280","article-title":"Major advances in oral drug delivery over the past 15 years","author":"Lipp","year":"2013","journal-title":"Am Pharm Rev"},{"key":"10.1016\/j.coph.2017.08.005_bib0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1208\/s12248-008-9020-0","article-title":"Use of the biopharmaceutical classification system in early drug development","volume":"10","author":"Ku","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.coph.2017.08.005_bib0290","first-page":"1681","article-title":"Biopharmaceutical classification system: an account","volume":"2","author":"Yasir","year":"2010","journal-title":"Int J PharmTech Res"},{"key":"10.1016\/j.coph.2017.08.005_bib0295","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/wnan.1185","article-title":"Peptide delivery using phospholipid micelles","volume":"4","author":"Banerjee","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.coph.2017.08.005_bib0300","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2017.08.005_bib0305","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/10717544.2013.819611","article-title":"Oral delivery of therapeutic proteins and peptides: a review on recent developments","volume":"20","author":"Gupta","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.coph.2017.08.005_bib0310","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.bmcl.2013.05.022","article-title":"Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity","volume":"23","author":"Lorenz","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.coph.2017.08.005_bib0315","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1074\/jbc.271.27.16139","article-title":"Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence","volume":"271","author":"Lortat-Jacob","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2017.08.005_bib0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React Funct Polym"},{"key":"10.1016\/j.coph.2017.08.005_bib0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2005.05.022","article-title":"An enteric-coated dry emulsion formulation for oral insulin delivery","volume":"107","author":"Toorisaka","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0330","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/jm049938j","article-title":"Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases","volume":"47","author":"Ekici","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2017.08.005_bib0335","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.11.9.1295","article-title":"Atazanavir: a novel HIV-1 protease inhibitor","volume":"11","author":"Piliero","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.coph.2017.08.005_bib0340","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1016\/j.coph.2017.08.005_bib0345","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0006-2952(87)90411-4","article-title":"Absorption of protein via the intestinal wall","volume":"36","author":"Ziv","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2017.08.005_bib0350","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.2042-7158.1985.tb03064.x","article-title":"Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs","volume":"37","author":"Fujii","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.coph.2017.08.005_bib0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2017.08.005_bib0360","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1359-6446(05)03489-6","article-title":"Gastrointestinal patch systems for oral drug delivery","volume":"10","author":"Tao","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2017.08.005_bib0365","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.drudis.2011.05.013","article-title":"Patches for improving gastrointestinal absorption: an overview","volume":"16","author":"Teutonico","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2017.08.005_sbref0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejpb.2017.01.003","article-title":"An overview of intestinal wafers for oral drug delivery","volume":"114","author":"Kirsch","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.coph.2017.08.005_bib0375","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0928-0987(00)00065-8","article-title":"Characterization of chitosan hydrochloride\u2013mucin interaction by means of viscosimetric and turbidimetric measurements","volume":"10","author":"Rossi","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.coph.2017.08.005_sbref0380","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/btm2.10015","article-title":"Intestinal mucoadhesive devices for oral delivery of insulin","volume":"1","author":"Banerjee","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.coph.2017.08.005_bib0385","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jconrel.2013.09.004","article-title":"Mucoadhesive intestinal devices for oral delivery of salmon calcitonin","volume":"172","author":"Gupta","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","article-title":"Oral delivery of macromolecules using intestinal patches: applications for insulin delivery","volume":"98","author":"Whitehead","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_sbref0395","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s10439-016-1558-x","article-title":"Oral delivery of exenatide and insulin using mucoadhesive intestinal devices","volume":"44","author":"Gupta","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.coph.2017.08.005_bib0400","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1015118923204","article-title":"Intestinal patches for oral drug delivery","volume":"19","author":"Shen","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.coph.2017.08.005_bib0405","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jconrel.2013.05.002","article-title":"A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine","volume":"172","author":"Gupta","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2007.06.052","article-title":"Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers","volume":"348","author":"Grabovac","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2017.08.005_bib0415","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.addr.2005.07.002","article-title":"Thiomers: a new generation of mucoadhesive polymers","volume":"57","author":"Bernkop-Schn\u00fcrch","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.coph.2017.08.005_bib0420","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jps.21480","article-title":"Design and in vivo evaluation of a patch system based on thiolated polymers","volume":"98","author":"Hoyer","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.coph.2017.08.005_bib0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0142-9612(01)00089-8","article-title":"Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein","volume":"23","author":"Eiamtrakarn","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.coph.2017.08.005_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2005.11.009","article-title":"Gastro-intestinal patch system for the delivery of erythropoietin","volume":"111","author":"Venkatesan","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0435","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10611860500331506","article-title":"Absorption of interferon alpha from patches in rats","volume":"13","author":"Ito","year":"2005","journal-title":"J Drug Target"},{"key":"10.1016\/j.coph.2017.08.005_sbref0440","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/1061186X.2017.1300664","article-title":"Intestinal micropatches for oral insulin delivery","volume":"25","author":"Banerjee","year":"2017","journal-title":"J Drug Target"},{"key":"10.1016\/j.coph.2017.08.005_bib0445","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0168-3659(02)00074-3","article-title":"Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery","volume":"81","author":"Ahmed","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0450","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2005.09.019","article-title":"Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability","volume":"109","author":"Tao","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0455","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1039\/b800604k","article-title":"Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics","volume":"8","author":"Ainslie","year":"2008","journal-title":"Lab Chip"},{"key":"10.1016\/j.coph.2017.08.005_bib0460","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/smll.200901254","article-title":"Microfabricated devices for enhanced bioadhesive drug delivery: attachment to and small-molecule release through a cell monolayer under flow","volume":"5","author":"Ainslie","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.coph.2017.08.005_bib0465","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2003.12.004","article-title":"Design of a novel hydrogel-based intelligent system for controlled drug release","volume":"95","author":"He","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.coph.2017.08.005_bib0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2003.03.001","article-title":"Devices based on intelligent biopolymers for oral protein delivery","volume":"277","author":"Peppas","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2017.08.005_bib0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2014.05.023","article-title":"pH-responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins","volume":"471","author":"Koetting","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2017.08.005_bib0480","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-responsive carriers for oral drug delivery: challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:03:21Z","timestamp":1570043001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217301194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":48,"alternative-id":["S1471489217301194"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2017.08.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal patch systems for oral drug delivery","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}